Approved Vendors means those sellers of products and services which Franchisor has approved and required Franchisee to utilize in the operation of the TapSnap Franchise.
Approved Vendors means the vendors set forth in Exhibit F, as amended from time-to-time pursuant to Section 17.3.
Approved Vendors. As defined in Section 1.7(j)(i).
Examples of Approved Vendors in a sentence
Bidders that are not Approved Vendors for the City of Taylor at the time bids or proposals are opened may be rejected.
As required by the SFA, Seller's rights and obligations under the Agreement may only be directly assigned or transferred to Approved Vendors.
As required by the ABP, Seller's rights and obligations under the Agreement may only be directly assigned or transferred to Approved Vendors.
A listing of awarded vendors will be available online at www.lyfordcisd.net under Departments/ Business Office/Board Approved Vendors 2021-2022.
A listing of awarded vendors will be available online at www.lyfordcisd.net under Departments/ Business Office/Board Approved Vendors 2020-2021.
More Definitions of Approved Vendors
Approved Vendors has the meaning set forth in Section 5.1
Approved Vendors means Eargo’s list of original equipment manufacturing approved vendors and/or suppliers from whom Supplier will procure all Components, and product processing services used in the manufacturing of the Units, as set forth in Appendix 3 (Approved Vendors) to the applicable SOW and updated by Eargo from time to time.
Approved Vendors has the meaning set forth in Section 9.1.
Approved Vendors shall have the meaning given in Section 9.3.
Approved Vendors means those vendors identified by each department head to the Purchasing Agent, who maintains a list of approved vendors for bidding purposes. The Purchasing Agent shall keep detailed lists for each department on file at all times.
Approved Vendors has the meaning set forth in Section 9.3. 1.6 “Assignment” has the meaning set forth in Section 4.7. 1.7 “BCMA” means B-cell maturation antigen. 1.8 “Belamaf” has the meaning set forth in the Recitals hereto. 1.9 “Bioanalytical Testing” has the meaning set forth in Section 9.3. 1.10 “Biomarkers” mean any naturally occurring molecule, gene or characteristic by which a particular pathological or physiological process can be identified and serially monitored during a therapeutic intervention, including blood (including cells, RNA and circulating multiple myeloma cells (CMMCs)), serum (including cytokines and sBCMA), plasma (including cfDNA), tissue and tumors (including FFPE bone marrow aspirate and biopsy Samples). 1.11 “Biomarker Testing” has the meaning set forth in Section 9.2. 1.12 “Business Day” means any day other than (a) a Saturday, Sunday or any public holiday in Boston, Massachusetts or London, England; and (b) a day falling within the time period from and including 24 December up to and including 1 January. 1.13 “cGMP” means the current Good Manufacturing Practices officially published and interpreted by EMA, FDA and other applicable Regulatory Authorities that may be in effect from time to time and are applicable to the Manufacture of the Compounds. These include requirements set forth in FDA’s regulations at 21 CFR Parts 11, 210, 211 and 600, as applicable to the processing, manufacture, handling, receipt, packaging, labelling, release and distribution of products and services subject to this Agreement. 1.14 “Change of Control” of a Party means any of the following, in a single transaction or a series of related transactions: (a) the sale or disposition of all or substantially all of the assets of such Party to a Third Party, (b) the direct or indirect acquisition by a Third Party (other than an employee benefit plan (or related trust) sponsored or maintained by such Party or any of its Affiliates) of beneficial ownership of more than fifty percent (50%) of
Approved Vendors means those vendors listed in ANNEX 6, as well as any other vendor that the Parties agree in writing shall be an Approved Vendor or that is deemed an Approved Vendor pursuant to Section 4.4. For purposes of clarity, DSM agrees that all vendors approved by DSM prior to the Effective Date for the supply of an API or an Excipient that is used in Product shall be listed in ANNEX 6 and all vendors approved by DSM after the Effective Date, for reasons other than at OMEROS’ request, for the supply of an API or an Excipient that is used in Product shall be added to ANNEX 6 by amendment at OMEROS’ request and without cost.